Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Getz

Showing results (301-310 of 397) with videos related to

Pageof 40
Sort By:
Nature|July 5, 2023
Therapy-induced APOBEC3A drives evolution of persistent cancer cellsHideko Isozaki, Ramin Sakhtemani, Ammal Abbasi, et al.
Nature Communications|June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplantTarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.
Nature|January 25, 2023
Author Correction: The evolutionary history of 2,658 cancersMoritz Gerstung, Clemency Jolly, Ignaty Leshchiner, et al.
Science (New York, N.Y.)|July 30, 2011
The mutational landscape of head and neck squamous cell carcinomaNicolas Stransky, Ann Marie Egloff, Aaron D Tward, et al.
Cell|January 12, 2019
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, et al.
Nature Biotechnology|April 23, 2014
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancerJens G Lohr, Viktor A Adalsteinsson, Kristian Cibulskis, et al.
Nature Genetics|January 14, 2014
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomasPriscilla K Brastianos, Amaro Taylor-Weiner, Peter E Manley, et al.
Cell|July 24, 2012
A landscape of driver mutations in melanomaEran Hodis, Ian R Watson, Gregory V Kryukov, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Nature|February 11, 2011
The genomic complexity of primary human prostate cancerMichael F Berger, Michael S Lawrence, Francesca Demichelis, et al.
Pageof 40

Showing results (301-310 of 397) with videos related to

Sort By:
Pageof 40
Nature|July 5, 2023
Therapy-induced APOBEC3A drives evolution of persistent cancer cellsHideko Isozaki, Ramin Sakhtemani, Ammal Abbasi, et al.
Nature Communications|June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplantTarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.
Nature|January 25, 2023
Author Correction: The evolutionary history of 2,658 cancersMoritz Gerstung, Clemency Jolly, Ignaty Leshchiner, et al.
Science (New York, N.Y.)|July 30, 2011
The mutational landscape of head and neck squamous cell carcinomaNicolas Stransky, Ann Marie Egloff, Aaron D Tward, et al.
Cell|January 12, 2019
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, et al.
Nature Biotechnology|April 23, 2014
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancerJens G Lohr, Viktor A Adalsteinsson, Kristian Cibulskis, et al.
Nature Genetics|January 14, 2014
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomasPriscilla K Brastianos, Amaro Taylor-Weiner, Peter E Manley, et al.
Cell|July 24, 2012
A landscape of driver mutations in melanomaEran Hodis, Ian R Watson, Gregory V Kryukov, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Nature|February 11, 2011
The genomic complexity of primary human prostate cancerMichael F Berger, Michael S Lawrence, Francesca Demichelis, et al.
Pageof 40